Achievement of Complete Remission (CR) with Measurable Residual Disease (MRD) Negativity Is Highly Prognostic in Patients (pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) Receiving First Salvage Chemotherapy
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Nicholas J. Short, Hind Rafei, Naval G. Daver, Hyunsoo Hwang, Jing Ning, Jorge E. Cortes, Jeffrey L. Jorgensen, Tapan M. Kadia, Courtney D. DiNardo, Sa A Wang, Elias Jabbour, Uday Popat, Betul Oran, Marina Y Konopleva, Guillermo Garcia-Manero, Gautam M. Borthakur, Kapil N. Bhalla, Ghayas C. Issa, Hagop M. Kantarjian, Farhad Ravandi
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2988253585